PTC Therapeutics
NasdaqGS:PTCT
$ 64,54
$-1,88 (-2,83%)
64,54 $
$-1,88 (-2,83%)
End-of-day quote: 03/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$7,62
Earnings Per Share
$20,91
Revenue Per Share
97,28%
Gross Margin %
$5,34 B
Market Cap
$2,03 B
Long-Term Debt
Earnings Per Share
$7,62
Revenue Per Share
$20,91
Gross Margin %
97,28%
Market Cap
$5,34 B
Long-Term Debt
$2,03 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share $7,62 $-3,94 $-5,63 $-7,35 $-7,43 $-5,04 $-4,27 $-2,33 $-2,02 $-4,17 $-5,07 $-2,97 $-5,17
Earnings Earnings $630,71M $-310,75M $-431,31M $-542,58M $-530,20M $-354,41M $-267,43M $-136,07M $-84,44M $-144,12M $-173,75M $-100,06M $-123,05M
RPS Revenue Per Share $20,91 $10,23 $12,24 $9,47 $7,55 $5,41 $4,90 $4,53 $4,65 $2,39 $1,07 $0,75 $1,46
Revenue Revenue $1,73B $806,78M $937,82M $698,80M $538,59M $380,77M $306,98M $264,73M $194,39M $82,71M $36,77M $25,25M $34,70M
OCF Operating Cash Flow $909,59M $-107,69M $-158,42M $-356,65M $-251,33M $-194,07M $-98,64M $-27,64M $-10,06M $-103,57M $-124,34M $-57,27M $-46,92M
FCF Free Cash Flow $860,00M $-114,19M $-186,86M $-388,67M $-279,55M $-211,91M $-112,40M $-34,74M $-13,16M $-105,34M $-127,06M $-61,94M $-47,77M
OM Operating Margin 49,49% -18,19% -37,26% -62,95% -69,62% -90,23% -62,80% -35,75% -33,07% -159,67% 0,00% 0,00% -130,85%
GM % Gross Margin % 97,28% 26,64% 21,94% 0,38% -6,39% -16,34% 12,18% 30,25% 37,22% -42,23% -231,33% -216,25% -58,16%
FCFS Free Cash Flow Per Share $5,17 $-2,37 $-3,73 $-7,10 $-4,78 $-3,79 $-2,45 $-0,93 $-2,31 $-3,09 $-3,78 $-1,96 $-3,72
LT Debt Long-Term Debt $2,03B $2,11B $1,90B $1,26B $956,59M $967,88M $293,86M $141,35M $144,97M $98,22M $91,85M N/A N/A
Sha. Stocks 82,77M 78,87M 76,61M 73,82M 71,36M 70,32M 62,63M 58,4M 41,8M 34,56M 34,27M 33,69M 23,8M
×